EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Metformin Use and Risk of Incident Hearing Loss Among Participants With Diabetes: A UK Biobank Cohort Study

Xijian Xin, Kun Zhang, Wenhe Yu, Jiaxin Liu, Liying Gao, Mingqi Li, Wenwen Zhu, Wenming Jia, Bo Hou, Ying Liu, Hao Bai, Liyong Chen, Hanbing Zhang, Ming Lv, Xinbo Xu

Diabetes, Obesity and Metabolism · 2026-12 · 28 (12) · 11178-11193

DOI: 10.1111/dom.71306 ↗
AbstractBibliografische Angaben

Abstract

ABSTRACT Aims To investigate the association between baseline metformin use and incident hearing loss among participants with diabetes in the UK Biobank. Materials and Methods This study included participants from the UK Biobank who had been diagnosed with diabetes before baseline and had no evidence of hearing loss ( N = 24 981). Metformin use was determined based on self‐reported medication use at the baseline assessment. Incident hearing loss was ascertained using a composite definition based on speech‐reception‐threshold estimate, hearing aid use, cochlear implantation and relevant ICD‐10 diagnoses during follow‐up. Cox proportional hazards models were used, with analyses stratified by sex and adjusted for demographic, lifestyle, socioeconomic, clinical factors, noise exposure, use of antidiabetic medications and renal function. Results During approximately 12 years of follow‐up, 725 and 385 incident hearing loss events were observed among male and female participants, respectively. Sex‐stratified analyses showed that, among men with diabetes, baseline metformin use was associated with a lower risk of incident hearing loss (fully adjusted model: hazard ratio [95% confidence interval], 0.846 [0.725–0.987], p = 0.0339), and this association remained generally stable across multiple sensitivity analyses. In contrast, among women with diabetes, no statistically significant association was observed between metformin use and the risk of incident hearing loss (fully adjusted model: hazard ratio [95% confidence interval], 0.977 [0.790–1.208], p = 0.8290). Further interaction analysis showed that the interaction term between metformin use and sex was not statistically significant ( p for interaction = 0.260). Conclusions In participants with diabetes from the UK Biobank, baseline metformin use was associated with a lower risk of incident hearing loss among men, whereas no significant association was observed among women. However, the interaction term between metformin use and sex was not statistically significant; therefore, it cannot yet be concluded that this association differed by sex.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →